Hypothyroidism: The Evidence-Based Supplement Protocol

6 min read ·

Hypothyroidism is treated with levothyroxine — full stop. Supplements have a narrow but real adjunctive role addressing the common nutritional deficiencies that overlap with hypothyroid presentations, plus selenium in autoimmune (Hashimoto's) variants. They do NOT substitute for thyroid hormone replacement.

Selenium, 100–200 mcg Daily — Hashimoto's Specifically

Multiple Italian and German RCTs in Hashimoto's thyroiditis have shown selenium 200 mcg daily as selenomethionine reduces anti-TPO antibody titers and improves perceived wellbeing over 6–12 months. The effect on actual thyroid function is smaller; this is primarily an autoimmune-modulation intervention. Cap at 200 mcg — chronic intake above 400 mcg is associated with type 2 diabetes risk and selenosis.

Iodine — Adequacy Only, Not Megadosing

Iodine deficiency is the most common cause of hypothyroidism globally but is rare in industrialized countries with iodized salt. The 150 mcg RDA is the target. Megadose iodine (>1,000 mcg) WORSENS Hashimoto's and can precipitate hyperthyroidism (Jod-Basedow phenomenon) in nodular thyroid disease. Avoid kelp supplements with unpredictable iodine content. See our iodine piece.

Iron — Repletion if Ferritin Low

Iron deficiency impairs T4-to-T3 conversion and is associated with persistent hypothyroid symptoms despite normalized TSH. Test ferritin; target 50+ ng/mL for symptomatic improvement. Take iron 4+ hours apart from levothyroxine to avoid absorption interference. See iron recovery stack.

Vitamin B12 — Test, Replete if Low

Autoimmune hypothyroidism cohorts have a 30–40% prevalence of subclinical B12 deficiency due to overlap with pernicious anemia and atrophic gastritis. Test serum B12 + MMA. Replete oral or IM as indicated. See B12 form piece.

Vitamin D — Repletion in Deficiency

Lower 25-OH-D is associated with higher TPO antibody titers in Hashimoto's. Repletion modestly reduces antibody load in some trials. Treat to 30–50 ng/mL. See vitamin D piece.

What NOT to Take

Avoid desiccated thyroid (NDT) and "thyroid glandular" supplements — supply unpredictable, dose unstandardized, contamination case reports. See our glandular piece. Avoid biotin (B7) megadoses — interferes with thyroid lab assays producing false readings. Skip kelp/seaweed megadoses. Avoid soy isoflavones at high dose when starting levothyroxine — may impair absorption. Don't combine ashwagandha with levothyroxine without endocrine input — it may push from hypo toward euthyroid or hyper. See ashwagandha thyroid risk.

How to Run the Protocol

Levothyroxine first — supplement to ferritin 50+ ng/mL, B12 to MMA normal, vitamin D 30+ ng/mL. For Hashimoto's, add selenium 200 mcg daily. Take supplements ≥4 hours apart from levothyroxine. Re-test TSH 6 weeks after any supplement change that could affect absorption. Track symptoms — persistent fatigue despite TSH in range is often iron or B12 deficiency. See condition page.

Sources

  1. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D. "Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis." Thyroid, 2010;20(10):1163-1173. PMID: 20883174. DOI: 10.1089/thy.2009.0351.
  2. Krysiak R, Okopien B. "The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis." JCEM, 2011;96(7):2206-2215. PMID: 21508145. DOI: 10.1210/jc.2010-2986.
  3. Zimmermann MB, Boelaert K. "Iodine deficiency and thyroid disorders." Lancet Diabetes & Endocrinology, 2015;3(4):286-295. PMID: 25591468. DOI: 10.1016/S2213-8587(14)70225-6.
  4. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ. "Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation." Thyroid, 2004;14(12):1084-1090. PMID: 15650365. DOI: 10.1089/thy.2004.14.1084.
  5. Garber JR, Cobin RH, Gharib H, et al. "Clinical practice guidelines for hypothyroidism in adults." Endocrine Practice, 2012;18(6):988-1028. PMID: 23246686. DOI: 10.4158/EP12280.GL.